What is the median sales figure for the Mid-Lower 25% of Learningrx centers?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
| Sample: | Top 25% | Mid-Top | Mid-Lower | Bottom | |
|---|---|---|---|---|---|
| 25% | 25% | 25% | |||
| # of Centers: | 11 | 10 | 10 | 10 | 4 |
| Top Sales | $893,375 | $486,808 | $287,188 | $167,835 | $376,730 |
| Low Sales | $507,737 | $300,712 | $172,105 | $35,673 | $133,094 |
| Median Sales | $601,971 | $391,046 | $229,711 | $75,215 | $195,526 |
| Average Sales | $631,577 | $402,343 | $229,935 | $85,218 | $225,219 |
| Centers meeting or | 2 / 18% | 5 / 50% | 5 / 50% | 3 / 30% | 1 / 25% |
| exceeding average: |
Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 46–48)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the median sales figure for the Mid-Lower 25% of centers is $229,711. This data is based on the performance of 45 Learningrx franchised centers in the United States that had complete data and were open for the full 12 months during the fiscal year ending September 30, 2024. The centers are divided into quartiles based on their total revenues. The Mid-Lower 25% represents the third quartile of centers.
For a prospective Learningrx franchisee, this figure provides a benchmark for the expected sales performance of a center in the mid-lower range. It's important to note that this is a median, meaning half of the centers in this quartile performed above this figure, and half performed below. The FDD also provides the top and low sales figures for this group, which were $287,188 and $172,105, respectively, giving a range of potential outcomes within this quartile.
It is important to consider that Learningrx states that individual results may differ, and there is no assurance that a new franchisee will earn as much. The FDD also notes that written substantiation for the financial performance representation will be made available to the prospective franchisee upon reasonable request. Prospective franchisees should carefully review this substantiation and consider their own market conditions and business acumen when evaluating this financial performance representation.